Twist Bioscience Signs Antibody Discovery Collaboration With Medisix Therapeutics To Develop T-Cell Therapies
Twist Bioscience Corporation, A Company Enabling Customers To Succeed Through Its Offering Of High-Quality Synthetic Dna Using Its Silicon Platform, And Medisix Therapeutics, A Cell Therapy Company Creating Novel Therapeutics To Target T-Cell Leukemia And Lymphoma, Today Announced A Collaboration To Discover Novel Antibodies Against Five Undisclosed Targets.Under The Terms Of The Collaboration, Twist Will Leverage Its Proprietary Library Of Libraries To Discover Five Novel Antibodies Directed Against Medisix
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!